<i>HORMAD1</i> overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers
Rania El Botty(Université Paris Sciences et Lettres), Elisabetta Marangoni(Université Paris Sciences et Lettres)
Cited by 9
Related Papers
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers
|Nature Communications|2023|96
Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts
|Molecular Cancer Therapeutics|2012|45
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
|British Journal of Cancer|2010|44